Custom Peptide Mazdutide High purity with the best price | 5mg 10 mg vials Lyophilized Powder | MAZ5 MAZ10 in stock
5 Inquiries
2259884-03-0
Pharmaceutical Grade
99%
CHINA ANY PORT
TNJONE
10 Vial/Box, 5mg, 10mg
2025-12-12
Semaglutide,Tirzepatide,API,Vitamins,Food Additive
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Basic Info-
Product Name:
Mazdutide
Other Name:Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)
CAS No.:2259884-03-0
Molecular Weight:0
EC Number:884-103-0
Color/Form:White to off-white
Categories:
Research-
Class:
Dual GLP-1R/GCGR agonist (long-acting peptide)
Status:Investigational — Phase 3 (China)
Mechanism:A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves. Administered once weekly.
EC50 (GLP1R Ki):28.6 nM
EC50 (GCGR Ki):17.7 nM
Source:GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI
Clinical Development:
References-
PubChem:Literature:
GlpBio: Mazdutide (CAS 2259884-03-0); eClinicalMedicine: Innovent Phase Ib results (2022); ClinicalTrials.gov: DREAMS-1 (NCT04930343)
Disclaimer:Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Semaglutide,Tirzepatide,API,Vitamins,Food Additive
-
Location:
No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New City, Xi 'an, Shaanxi Province
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2019
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mazdutide
25 MG Aug 12, 2026
Nigeria
Mazdutide 10mg
20 PCS Mar 7, 2026
United States
Mazdutide
30 MG Jul 15, 2024
United Kingdom
Mazdutide
1 KG Feb 10, 2026
United States
Mazddultide cas
2 MT Nov 14, 2025 Post an enquiry for this product
More from this Seller
-
-
-
High quality at discounted prices tesa powder and vial
Pharmaceutical Grade / 99%
$90-115/G FOB
-
-
-
-
Pharmaceutical Product Peptides Powder Cagrilintide Retatrutide Semax Mots-C HMG
Pharmaceutical Grade / 99%
$40-45/MT FOB
-
-
-
-
Factory Supply Best Price 99% Pregabalin powder CAS 148553-50-8 Pregabalin
Pharmaceutical Grade / 99%
-
-
-
-
Hot Sell Pharmaceutical 3-Hydroxytyramine 99% Purity CAS 51-61-6 Dopamine Powder
Pharmaceutical Grade / 98%
-
-
-
-
Hot Selling Pharmaceutical Raw Materials Azithromycin Powder CAS 83905-01-5
Pharmaceutical Grade / 99%
$140-155/KG FOB
-